Caliper And Covaris Establish Co-Marketing Agreement To Simplify Next Generation Sequencing

– Integration of DNA shearing technology with automation and microfluidics solutions simplifies next generation sequencing workflows and improves sample quality –

HOPKINTON, Mass.—Feb. 23, 2011 /PRNewswire/—Caliper Life Sciences, Inc. (CALP: 6.64 -0.15 -2.21%) and Covaris Inc., Woburn, Mass., today announced a co-marketing agreement which will leverage Covaris’ acoustic DNA shearing platforms and Caliper’s automation and microfluidics technologies to develop automated workflows for next generation sequencing experiments. Caliper has developed a complete suite of solutions for library construction, sample analysis, and nucleic acid fractionation, which significantly reduces manual manipulations, increases throughput and improves sample-to-sample consistency.

“Our Sciclone NGS, LabChip GX, and LabChip XT have become critical tools in leading next generation sequencing laboratories already utilizing Covaris’ technology,” said Kevin Hrusovsky, President and Chief Executive Officer of Caliper Life Sciences. “This collaboration is a logical next step toward simplifying workflows for scientists challenged with meeting the growing demands of next generation sequencing sample preparation. As sequencing technologies move from the lab bench to the clinic, it is critical that integrated solutions offer consistency and sample tracking.”

“Covaris provides a wide variety of next-gen sample prep solutions for the evolving needs of sequencing laboratories relative to nucleic acid shearing and sample extraction,” said Jim Laugharn, Covaris President and Chief Executive Officer. “Covaris recognizes the importance of high quality sample preparation as a fundamental component for advanced life science systems, such as in Next Generation DNA Sequencing.”

Covaris sample preparation technology, which is based on its industry-standard Adaptive Focused Acoustic™ (AFA) technology, brings quality, speed, and efficiency to biological and chemical sample preparation with the single-sample S220, the multi-sample E220 and high throughput parallel-processing LE220. The isothermal and non-contact Covaris method accelerates next-generation DNA sequencing sample preparation by providing a highly predictable and reproducible DNA shearing instrumentation, consumables, and applications to the next-gen workflow.

Caliper’s portfolio of microfluidic and automation solutions that uniquely enable sample preparation for high throughput sequencing. Caliper’s sequencing tools include the LabChip XT for nucleic acid fractionation, the LabChip GX for library quantification and sizing, the recently launched LabChip DS for purity and quality control, the Zephyr® Genomics Workstation for automated nucleic acid extraction and reaction setup, and the Sciclone® NGS Workstation, which includes validated protocols for library preparation, sequence capture, and sample normalization. For additional information on Caliper’s solutions for next generation sequencing, please visit www.caliperls.com/genomics.

About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper’s portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions.

For more information please visit http://www.caliperLS.com.

About Covaris, Inc.
Covaris, Inc. provides advanced sample preparation systems for life and analytical science. Our sample prep technologies support a wide variety of applications including next-generation DNA sequencing, ChIP, proteomics, and compound management. Our patented Adaptive Focused Acoustic (AFA) technology enables a high energy density to bring unsurpassed speed and efficiency to biological and chemical sample preparation. The AFA process, based on shock wave physics, delivers controlled, precise, and accurate energy to biological and chemical samples.

Information about Covaris is available at https://www.covaris.com.

Caliper, LabChip XT, LabChip GX, LabChip DS, Zephyr and Sciclone are registered trademarks of Caliper Life Sciences, Inc. Covaris, S220, E220, LE220 and Adaptive Focused Acoustics are registered trademarks of Covaris, Inc.

SOURCE Caliper Life Sciences, Inc.

Covaris Receives the Society for Laboratory Automation and Screening (SLAS) New Product Award at LabAutomation 2011

WOBURN, MA—February 8, 2011—The Covaris® LE220™ Focused-ultrasonicator has received the prestigious SLAS New Product Award at the LabAutomation 2011 conference in Palm Springs CA. With over 4,400 attendees, LabAuto is the premier laboratory automation conference and exhibition, bringing science, technology, and industry together.

Breakthrough products introduced at LabAutomation are evaluated by a team of industry experts. Each year, the best and most promising new products are recognized with the SLAS New Product Award. Covaris is very pleased to announce that for 2011, the LE220 is a recipient of the New Product Award designation.

The LE220 was chosen for the New Product Award from more than 400 LabAutomation 2011 exhibitors, based on its technical originality, anticipated impact on the field of laboratory automation, supporting data that reflects universal scientific methodology, and market demand. According to Jim Laugharn, Founder and CEO, “The NPA award is significant recognition and is an affirmation that the patented, controlled AFA physicochemical process is indeed a unique technology platform. This award also reflects the increasing importance of sample preparation as a fundamental component of advanced life science systems, such as in Next Generation DNA Sequencing.”

The LE220 Ultra-sonicator
The LE220 is specifically designed for high-throughput, parallel-processing operations utilizing the Covaris Adaptive Focused Acoustic™ (AFA™) technology. The LE220 is ideal for next-gen nucleic acid sequencing, compound dissolution, tissue/cell lysis applications, and other high-throughput applications. With DNA shearing performance characteristics matching industry-standard Covaris S-series and E-series instruments, the LE220 reproducibly shears DNA to desired lengths, in a multi-sample parallel-processing mode. The LE220 is designed to improve sample processing throughput 8 fold over single sample methods in a 96 tube format (32 fold in a 384 well format).

About Covaris, Inc.
Covaris, Inc. provides advanced sample preparation systems for life and analytical science. Our sample prep technologies support a wide variety of applications including next-generation DNA sequencing, ChIP, proteomics, and compound management. Our patented Adaptive Focused Acoustic (AFA) technology enables a high energy density to bring unsurpassed speed and efficiency to biological and chemical sample preparation. The AFA process, based on shock wave physics, delivers controlled, precise, and accurate energy to biological and chemical samples.

Information about Covaris is available at https://www.covaris.com.

About SLAS
Founded in 1996, SLAS is a worldwide organization providing leadership and educational benefits on the utilization of automation technologies, robotics, and artificial intelligence in order to improve the quality, efficiency, and relevance of laboratory analysis within and across multiple industries. Laboratory Automation includes podium presentations, poster sessions, and exhibiting companies from all over the world showcasing the latest in laboratory automation technologies.

Information about SLAS is available at http://www.slas.org.

Contact:
Brian J. Paras
Director, Strategic Marketing & International Sales
Covaris, Inc.
14 Gill Street, Unit H
Woburn, Massachusetts
USA 01801-1721
bparas@covaris.com
Tel: 001 781.932.3959 ext. 206
web: www.covaris.com

Tecan and Covaris Co-Market Freedom EVO® with Adaptive Focused Acoustics™

Covaris Tecan press release pictureMännedorf, Switzerland—November 18, 2010—Tecan is collaborating with Covaris, Inc., a rapidly growing company providing advanced sample preparation solutions for life and analytical science, to co­promote the Freedom EVO® liquid handling platform with integrated Adaptive Focused Acoustics™ (AFA). This co-marketing agreement will allow customers to benefit from both the advanced capabilities of Tecan’s Freedom EVO systems and Covaris’ controlled non-contact acoustic sample preparation technology.

Covaris’ AFA systems have already been successfully integrated into the Freedom EVO platform for several applications, and this joint offering will now be available to customers worldwide for sample preparation, compound management and next generation sequencing applications.

Kevin Moore, Tecan’s Director of Market and Application Management for BioPharma, said: “AFA is gaining widespread acceptance in the compound management community for rapid thawing, mixing and dissolution of samples, as well as for DNA shearing in the exciting area of next generation sequencing. We are extremely pleased to be working together with Covaris to provide valuable automated solutions to our customers working in these areas.”

“Covaris is delighted to enter into partnership with Tecan to provide researchers with next generation automated sample preparation,” said Jim Laugharn, Covaris President and CEO. “High quality, reproducible sample preparation is the critical first step in improving analytical results, and Covaris’ highly controlled system sets the standard for today’s rapidly advancing analytical technologies and sophisticated assays. This collaboration between Tecan and Covaris provides scalable, turn-key automated sample preparation solutions for a wide variety of key life science applications.”

To find out more on Tecan’s Freedom EVO workstations, visit http://www.tecan.com/freedomevo
To find out more about our solution, visit http://www.tecan.com/covaris
To find out more on Covaris’ Adaptive Focused Acoustics, visit https://www.covaris.com

For more information please contact
Tecan Trading AG
Tanja Kaiser
Seestrasse 103
CH-8708 Männedorf
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
info@tecan.com
www.tecan.com

About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).

For more information about Covaris Inc., please contact
Covaris, Inc.
Brian Paras
14 Gill Street, Unit H
Woburn, MA  01801
bparas@covaris.com
www.covaris.com
001 781.932.3959 ext. 206

About Covaris, Inc.
Covaris, Inc. (www.covaris.com) provides advanced sample preparation systems for life and analytical sciences. We design, manufacture, and distribute products that support a wide variety of applications including next-generation DNA sequencing, ChIP, proteomics, and compound management. Our patented Adaptive Focused Acoustic (AFA) technology brings unsurpassed speed and efficiency to sample preparation. The AFA process, which is based on shock wave physics, delivers controlled, precise and accurate acoustic energy to biological and chemical samples. Covaris sells instruments in more than 30 countries throughout the world.

Covaris Signs Co-Marketing Agreement with Illumina to Combine Next-Gen Sequencing Platforms with Controlled DNA Shearing

WOBURN, MA—September 10, 2010—Covaris Inc. (a privately-held MA based company) today announced that it has signed a co-marketing agreement with Illumina, Inc. (NASDAQ:ILMN) making Covaris DNA shearing technologies the recommended method of shearing with Illumina next-generation sequencing product lines, including HiSeq, HiScanSQ, and Genome Analyzer. In addition, the proprietary Covaris process enables higher recoveries for nucleic acid extraction, tissue homogenization, chromatin shearing, protein digestion, and cell lysis. The highly controlled Covaris technology is isothermal and non-contact, ensuring molecular stability throughout the sample preparation process. Important for next-generation genetic analysis, the Covaris system allows customers to rapidly and precisely scale up sample processing capability. The Illumina-Covaris partnership will bring industry leading next-generation DNA shearing performance to Illumina’s sequencing customers

About Covaris, Inc.
Covaris, Inc. provides advanced sample preparation systems for life and analytical science. Our sample prep technologies support a wide variety of applications including next-generation DNA sequencing, ChIP, proteomics, and compound management. Our patented Adaptive Focused Acoustic (AFA) technology enables a high energy density to bring unsurpassed speed and efficiency to biological and chemical sample preparation. The AFA process, based on shock wave physics, delivers controlled, precise, and accurate energy to biological and chemical samples.

Information about Covaris is available at https://www.covaris.com.

Contact:
Brian J. Paras
Covaris, Inc.
14 Gill Street, Unit H
Woburn, Massachusetts
USA 01801-1721
bparas@covaris.com
Tel: 001 781.932.3959 ext. 206
web: www.covaris.com